Results 1 to 10 of about 8,569 (200)

Telemonitoring for Chronic Heart Failure: Narrative Review of the 20-Year Journey From Concept to Standard Care in Germany

Journal of Medical Internet Research
BackgroundChronic heart failure (CHF) is a major cause of morbidity and mortality worldwide, placing a significant burden on health care systems.
Sebastian Spethmann, Gerhard Hindricks, Kerstin Koehler, Stefan Stoerk, Christiane E Angermann, Michael Böhm, Birgit Assmus, Sebastian Winkler, Martin Möckel, Mirja Mittermaier, Monika Lelgemann, Daniel Reuter, Ralph Bosch, Alexander Albrecht, Stephan von Haehling, Thomas M Helms, Stefan Sack, Tarek Bekfani, Jan Wolfgang Gröschel, Magdalena Koehler, Christoph Melzer, Jan Wintrich, Bettina Zippel-Schultz, Georg Ertl, Claus Vogelmeier, Nikolaos Dagres, Jasmin Zernikow, Friedrich Koehler   +27 more
doaj   +3 more sources

Questioning Patient Subgroups for Benefit Assessment: Challenging the German Gemeinsamer Bundesausschuss Approach [PDF]

Value in Health, 2014
Questioning Patient Subgroups for Benefit Assessment: Challenging the German Gemeinsamer Bundesausschuss Approach Jorg Ruof, MD, MPH, MBA*, Charalabos-Markos Dintsios, PhD, MPH, Friedrich Wilhelm Schwartz, MD Roche Pharma AG, Grenzach-Wyhlen, Germany; Hannover Medical School, Hannover, Germany; German Association of Researchbased Pharmaceutical ...
Ruof, Jörg, Dintsios, Charalabos-Markos, Schwartz, Friedrich Wilhelm   +2 more
openaire   +3 more sources

Quality contract ‘prevention of postoperative delirium in the care of elderly patients’ study protocol: a non-randomised, pre–post, monocentric, prospective trial

BMJ Open, 2023
Introduction Postoperative delirium (POD) is seen in approximately 15% of elderly patients and is related to poorer outcomes. In 2017, the Federal Joint Committee (Gemeinsamer Bundesausschuss) introduced a ‘quality contract’ (QC) as a new instrument to ...
Sascha Treskatsch, Claudia Spies, Sophie K Piper, Jochen Kruppa, Felix Balzer, Ursula Marschall, Kathrin Scholtz, Dieter Schmidt, Joern Kiselev, Moritz Höft, Fatima Yürek, Julian-Dominic Zimmermann, Elisa Weidner, Armin Hauß, Enrico Dähnert, Daniel Hadzidiakos, Natia Sichinava, Oscar Andrés Retana Romero, Laerson Hoff, Rudolf Mörgeli, Lennart Junge, Luzie Grüner, Antonia Eva Maria Harborth, Lisa Eymold, Tuba Gülmez, Elke Falk, Franziska Landgraf, Andreas Hölscher, Mani Rafii   +28 more
doaj   +2 more sources

Auswirkungen der neuen Dossieranforderungen

Monitor Versorgungsforschung, 2023
Bei Markteintritt oder Zulassungserweiterung eines neuen Arzneimittels sind pharmazeutische Unternehmer in Deutschland seit 2011 zur Einreichung eines AMNOG-Nutzendossiers beim G-BA verpflichtet.
Dr. rer. nat. Maria Katharina Schweitzer, Dr. rer. nat. Manuel Nico Dold, Dr. rer. nat. Astrid Genet, Klaus Gossens PhD, Dipl.-Math. Thomas Klein-Hessling, Nils Löffler MSc, Dr. phil. Matthias Rabel, Dr. PH Andrej Rasch, Jessica Schmelcher MSc, Dr. rer. nat. Sebastian Werner, Natalia Wolfram   +10 more
doaj   +2 more sources

Health-related preferences of older patients with multimorbidity: an evidence map [PDF]

BMJ Open, 2019
Objectives To systematically identify knowledge clusters and research gaps in the health-related preferences of older patients with multimorbidity by mapping current evidence.Design Evidence map (systematic review variant).Data sources MEDLINE, EMBASE ...
Marjan Van Den Akker, Odette Wegwarth, Joerg J Meerpohl, Sharon E Straus, Tammy Hoffmann, Ferdinand M Gerlach, Christine Schmucker, Jeanet Blom, Truc Sophia Nguyen, Kristian Röttger, Christiane Muth, Maria-Sophie Brueckle   +11 more
doaj   +3 more sources

A scoping review of the use of minimally important difference of EQ-5D utility index and EQ-VAS scores in health technology assessment

Health and Quality of Life Outcomes
Objectives Estimates of minimally important differences (MID) can assist interpretation of data collected using patient-reported outcomes (PRO), but variability exists in the emphasis placed on MIDs in health technology assessment (HTA) guidelines.
Caroline Shaw, Louise Longworth, Bryan Bennett, Louise McEntee-Richardson, James W. Shaw   +4 more
doaj   +2 more sources

Wann hat der Gemeinsame Bundesausschuss (G-BA) ein Heilmittel als ein neues Heilmittel zu betrachten?

Monitor Versorgungsforschung
Die vom Gemeinsamen Bundesausschuss beschlossenen Richtlinien über die Verordnung von Heilmitteln in der vertragsärztlichen und -zahnärztlichen Versorgung dienen der Sicherung der medizinischen Versorgung mit Heilmitteln. Durch sie wird rechtsverbindlich
Mario Hellbardt BSc, Antonia Stolle MSc, Marjan Rip BSc, Dr. rer. nat. Edith Pfenning   +3 more
doaj   +2 more sources

OP54 Different Perceptions Of Additional Benefit By Payers And Providers: Discrepant Voting Within G-BA’s Benefit Appraisals [PDF]

Int J Technol Assess Health Care
Introduction Appraisal decisions on additional benefit of new medicines within the German health technology assessment (HTA) body Gemeinsamer Bundesausschuss (G-BA) are made by voting among the member of the G-BA plenary.
A. Rasch, Elaine Julian, Jörg Ruof
europepmc   +2 more sources

Leveraging EUnetHTA’s conceptual framework to compare HTA decision drivers in France, Italy, and Germany from a manufacturer’s point of view

Health Economics Review, 2018
Background Health Technology Assessments (HTA) procedures differ substantially across the various European countries. We reviewed recent appraisals of a pharmaceutical manufacturer in three major European markets (France; Italy; Germany) and identified ...
Giovanni Giuliani, Frederic Chassagnol, David Traub, Marlene Gyldmark, Ansgar Hebborn, Pierre Ducournau, Jörg Ruof   +6 more
doaj   +2 more sources

„Strategie der Optimierung bis zum Jahr 2035“

Monitor Versorgungsforschung, 2023
Im ersten Teil des MVF-Fachkongresses „Priorisierungskatalog Versorgungsforschung“, der am 13. Dezember 2022 online stattfand, mahnte Prof. Josef Hecken, unparteiischer Vorsitzender des G-BA und gleichzeitig Vorsitzender des beim G-BA angesiedelten ...
Peter Stegmaier
doaj   +1 more source